Kiniksa Pharmaceuticals
KNSA
KNSA
96 hedge funds and large institutions have $306M invested in Kiniksa Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $346M → $306M (-$40.3M)
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
Holders
96
Holding in Top 10
1
Calls
$2.44M
Puts
$1.77M
Top Buyers
| 1 | +$5.78M | |
| 2 | +$4.97M | |
| 3 | +$4.58M | |
| 4 |
LPC
Lion Point Capital
New York
|
+$4.22M |
| 5 |
Goldman Sachs
New York
|
+$3.55M |
Top Sellers
| 1 | -$8.93M | |
| 2 | -$2.87M | |
| 3 | -$2.81M | |
| 4 |
Renaissance Technologies
New York
|
-$1.44M |
| 5 |
Rafferty Asset Management
New York
|
-$1.04M |